Inequality of access to advanced therapies for patients with inflammatory arthritis: a postcode lottery?
Arvind KaulJatin MistryAnnamaria IagnoccoXenofon BaraliakosAilsa BosworthIain McNicolPublished in: Rheumatology advances in practice (2021)
Although patients at identical stages of their disease course should have access to the same NICE-approved AT, we found this is not the case for large parts of England. Inequality of access was found between regions, mirroring the variability that occurs between countries throughout Europe. Harmonization of access needs to be addressed by policymakers to ensure fairness in the way that clinicians and patients can access AT.